The estimated Net Worth of Matthew Sirovich is at least $2.38 Million dollars as of 24 November 2020. Matthew Sirovich owns over 86,239 units of PAVmed Inc stock worth over $1,623,836 and over the last 17 years Matthew sold PAVM stock worth over $756,604.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Sign up
Matthew Sirovich PAVM stock SEC Form 4 insiders trading
Matthew has made over 3 trades of the PAVmed Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently Matthew sold 86,239 units of PAVM stock worth $170,753 on 24 November 2020.
The largest trade Matthew's ever made was selling 200,921 units of PAVmed Inc stock on 28 May 2020 worth over $403,851. On average, Matthew trades about 48,395 units every 23 days since 2008. As of 24 November 2020 Matthew still owns at least 1,027,744 units of PAVmed Inc stock.
You can see the complete history of Matthew Sirovich stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Matthew Sirovich's mailing address?
Matthew's mailing address filed with the SEC is 152 W 57th St, New York, NY 10019, USA.
Insiders trading at PAVmed Inc
Over the last 9 years, insiders at PAVmed Inc have traded over $1,291,924 worth of PAVmed Inc stock and bought 370,262 units worth $523,987 . The most active insiders traders include Ira Scott Greenspan, Matthew Sirovich, and Michael J Glennon. On average, PAVmed Inc executives and independent directors trade stock every 73 days with the average trade being worth of $62,625. The most recent stock trade was executed by Michael J Glennon on 5 December 2022, trading 250,000 units of PAVM stock currently worth $160,000.
What does PAVmed Inc do?
pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.
What does PAVmed Inc's logo look like?
Complete history of Matthew Sirovich stock trades at Central Garden & Pet Co, Central Garden & Pet Co, and PAVmed Inc
PAVmed Inc executives and stock owners
PAVmed Inc executives and other stock owners filed with the SEC include:
-
Dr. Lishan Aklog M.D.,
Chairman & CEO -
Lishan Aklog,
Chairman of the Board, Chief Executive Officer -
Dennis M. McGrath CPA,
Pres, CFO & Corp. Sec. -
Dennis McGrath,
President, Chief Financial Officer and Corporate Secretary -
Brian DeGuzman,
Executive Vice President - Clinical Affairs, Chief Medical Officer -
Dr. Brian J. deGuzman M.D.,
Chief Medical Officer & Exec. VP of Clinical Affairs -
David Weild,
Independent Director -
Ronald Sparks,
Independent Director -
David Battleman,
Independent Director -
James Cox,
Independent Director -
Michael Glennon,
Independent Vice Chairman of the Board -
Mike Havrilla,
Director of Investor Relations -
Sunny Webb,
VP, Data & Analytics -
James Mitchell M.D.,
VP of Digital Health -
Shaun M. O'Neil,
Chief Commercial Officer -
Ira Scott Greenspan,
Director -
Joshua R Lamstein,
Director -
Richard F Fitzgerald,
CFO and Secretary -
Lishan Pavilion Venture Par...,
Chairman and CEO -
Matthew Sirovich,
10% owner -
Joan B Harvey,
Director -
Shaun O'neil,
Chief Operating Officer -
Debra White,
Director -
Lishan Aklog,
Chairman and CEO -
Timothy E Baxter,
Director -
Michael Adam Gordon,
General Counsel